XP-8121

· Xeris Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XP-8121, covering 2025-07-03 to 2025-07-03. Get the full timeline:

Most recent: Clinical Trial Update: Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism [Phase 2]